e-Drug3D

1410

cas 89365-50-4

CLASS

RESPIRATORY
SYMPATHOMIMETIC
BETA2-ADRENERGIC BRONCHODILATOR AGONIST

ROUTE (list)

INHALATION

PK parameters

PPB 96 PERCENT
t1/2 5.5 HOUR

MW 415.56
NB_atoms 30
XLogP 4.11
PSA 84.794
NB_HD 4
NB_HA 5
fsp3 0.52
Lipinski(0=no;1=yes) 1

FDA
NDA 020236 (pdf not found) INN (SALMETEROL XINAFOATE) SEREVENT (GLAXOSMITHKLINE) APPROVAL= AP YEAR= 1994 DISCONTINUED
NDA 020692 (pdf not found) INN (SALMETEROL XINAFOATE) SEREVENT (GLAXOSMITHKLINE) APPROVAL= AP YEAR= 1997
NDA 021077 (pdf not found) INN (FLUTICASONE PROPIONATE ; SALMETEROL XINAFOATE) ADVAIR DISKUS 100/50 (GLAXO GRP LTD) APPROVAL= AP YEAR= 2000
NDA 021254 (pdf not found) INN (FLUTICASONE PROPIONATE ; SALMETEROL XINAFOATE) ADVAIR HFA (GLAXO GRP LTD) APPROVAL= AP YEAR= 2006
NDA 208799 (pdf not found) INN (FLUTICASONE PROPIONATE ; SALMETEROL XINAFOATE) AIRDUO RESPICLICK (TEVA PHARM) APPROVAL= AP YEAR= 2017
NDA 208891 (pdf not found) INN (FLUTICASONE PROPIONATE ; SALMETEROL XINAFOATE) WIXELA INHUB (MYLAN) APPROVAL= AP YEAR= 2019
NDA 203433 (pdf not found) INN (FLUTICASONE PROPIONATE ; SALMETEROL XINAFOATE) FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE (HIKMA) APPROVAL= AP YEAR= 2020
NDA 213948 (pdf not found) INN (FLUTICASONE PROPIONATE ; SALMETEROL XINAFOATE) FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE (TEVA PHARMS USA) APPROVAL= AP YEAR= 2021